Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting
Erny-Albrecht, KM, Erdmann, E
Journal
- ISSN / E-ISSN
- — / —
- DOI
- 10.4414/smw.2009.12381 ↗
- Volume · Issue · Pages
- 139 · 1112 · —
- Publisher
- SMW supporting association
- Article URL
- https://smw.ch/index.php/smw/article/view/956 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
21 Mar 2009
Publisher publication date · source: Journal websites (OAI-PMH feeds of Open Journal Systems)
| Type | Date | Source |
|---|---|---|
| Publisher publication date | 21 Mar 2009 | Journal websites (OAI-PMH feeds of Open Journal Systems) |
Keywords (as given): Macrovascular events; Costeffectiveness; Switzerland; PRO active; Pioglitazone; type 2 diabetes mellitus
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- Swiss Medical Weekly
- Publication date used
- 21 Mar 2009 (Publisher publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.